Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects

Annals of Nutrition and Metabolism

Volumn 50, Issue 4, 2006, Pages 354-360

  De Luis, D A ^a   Aller, R ^a   Izaola, O ^a   Gonzalez Sagrado, M ^a   Conde, R ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

ALA54THR FABP2 polymorphism; Diet, lifestyle modification; Exercise; Obesity

Indexed keywords

ALANINE; C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN 2; INSULIN; INTERLEUKIN 6; PROTEIN; RESISTIN; THREONINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AEROBIC EXERCISE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALORIMETRY; CARBOHYDRATE INTAKE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DNA POLYMORPHISM; FAT INTAKE; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; IMPEDANCE; LIFESTYLE; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN INTAKE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; WILD TYPE;

ADIPOSE TISSUE; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, LDL; DIET, REDUCING; EXERCISE; FATTY ACID-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; LEPTIN; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RNA, MESSENGER; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 33746852382     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094299     Document Type: Article

References (37)

1. Aranceta J, Perez Rodrigo C, Serra Majem L: Prevalencia de la obesidad en España: estudio SEEDO 97. Med Clin (Barc) 1998;111:441-445.
2. Tuomilehto J, Lindström J, Eriksson JG; Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
3. Knowler WC, Barret-Connor E, Fowler SE; Diabetes Prevention Program Research Group: Reduction in incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
4. Matsuda M, Shimomura I, Sata M: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-37491.
5. Kumada M, Kihara S, Sumitsuji S: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-89.
6. Shimomura I, Hammer RE, Ikemoto S: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73-76.
7. Steppan CM, Bailey ST, Bhat S: The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
8. Matsuzawa Y: Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep 2005;7:58-62.
9. Okazaki T, Himeno E, Nanri H, Ogata H, Ikeda M: Effects of mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women. Clin Exp Pharmacol Physiol 1999;26:415-420.
10. Xenachis C, Samojlik E, Raghuwanshi MP, Kirschner MA: Leptin, insulin and TNF-alpha in weight loss. J Endocrinol Invest 2001;24:865-870.
11. Bastard JP, Jardel C, Bruckert E: Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-3342.
12. Hotta K, Funahashi T, Arita Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20: 1595-1599.
13. Besnard P, Niot I, Bernard A: Cellular and molecular aspects of fat metabolism in the small intestine. Proc Nutr Soc 1996;55:19-37.
14. Van Nieuwenhoven FA, Van der Vusse GJ, Glatz JF: Membrane-associated and cytoplasmic fatty acid binding proteins. Lipids 1996:31(suppl):S223-S227.
15. Ockner RK, Manning JA: Fatty acid binding protein in small intestine: identification, isolation and evidence for its role in cellular fatty acid transport. J Clin Invest 1974;54:326-338.
16. Baier LJ, Sacchettini JC, Knowler WC: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995;95:1281-1287.
17. Albala C, Santos JL, Cifuentes M: Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res 2004;12:340-345.
18. Duart Duart MJ, Arroyo CO, Moreno Frigols JL: Validation of a kinetic model for the reactions in RIA. Clin Chem Lab Med 2002;40:1161-1167.
19. Pfutzner A, Langefeld M, Kunt T, Lobig M: Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003;49:571-576.
20. Meier U, Gressner AM: Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511-1525.
21. Suominen P: Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004;50:219-221.
22. Lubrano V, Cocci F, Battaglia D, Papa A: Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 2005;19:110-114.
23. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP Jr: Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures. Cytometry B Clin Cytom 2004;61:35-39.
24. Sipilainen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M: Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 1997;82:2629-2632.
25. Carlsson M, Orho-Melander M, Hedenbro J, Almgren P, Groop LC: The T 54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. J Clin Endocrinol Metab 2000;85:2801-2804.
26. Georgopoulos A, Aras O, Tsai MY: Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 2000;85:3155-3160.
27. Georgopoulos A, Aras O, Noutsou M, Tsai MY: Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene. J Clin Endocrinol Metab 2002;87:3735-3739.
28. Agren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M: Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid binding protein 2 gene. Arterioscler Tromb Vasc Biol 1998;18:1606-1610.
29. Pratley RE, Baier L, Pan DA, Salbe AD, Storlien L, Ravussin E, Bogardus C: Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 2000:41:2002-2008.
30. Tahvanainen E, Molin M, Vainio S, Tiret L, Nicaud V, Farinaro E, Masana L, Ehnholm C: Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 2000;152:317-325.
31. Dworatzek P, Hegele R, Wolever T: Postprandial lipemia in subjects with threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. Am J Clin Nutr 2004;79:1110-1117.
32. Marin C, Perez Jimenez F, Gomez P, Delgado J, Paniagua JA, Lozano A, Cortés B, Jimenez Gomez Y, Gomez MJ: The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr 2005;82:196-200.
33. Hegele RA, Wolever TM, Store JA, Connelly PW, Jenkins DJ: Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur J Clin Invest 1997;27:857-862.
34. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW: Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003;27:875-888.
35. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
36. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K: Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003;11:1048-1052.
37. Ryan AS, Nicklas BJ, Berman DM, Elahi D: Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese premenopausal women. Int J Obes Relat Metab Disord 2003;27:1066-1071.